Home Newsfeeds Canaccord Genuity Downgrades Bioventus to Hold

Canaccord Genuity Downgrades Bioventus to Hold

Canaccord Genuity analyst Kyle Rose downgrades Bioventus (NASDAQ:BVS) from Buy to Hold.

byBenzinga Newsdesk

November 9, 2022

1 minute read

Canaccord Genuity analyst Kyle Rose downgrades Bioventus (NASDAQ:BVS) from Buy to Hold.

1606 Corp. Signs Product Distribution Agreement With SurgePays, Inc.

By Happy Mohamed

May 9, 8:43 AM

1606 Corp. (OTC:CBDW), an acquisition-based CBD holding company today announced that the company closed a distribution deal with SurgePays, Inc. (NASDAQ:SURG). Under this agreement, SurgePays has agreed to

CBDW

Canadian Marijuana Stock Slightly Up On Q2 Earnings: 9.3% YoY Revenue Growth, Reduced Net Loss

By Benzinga Newsdesk

August 14, 8:15 AM

Canadian cannabis company SNDL Inc. (NASDAQ: SNDL) reported Monday its financial results for the second quarter ended June 30, 2023, disclosing revenue of CA$244.5 million ($182 million), up by 9.3% from CA$223.7 million in the same period of 2022.

SNDL

Citigroup Maintains Neutral on Warrior Met Coal, Raises Price Target to $40

By Benzinga Newsdesk

February 17, 11:08 AM

Citigroup analyst Alexander Hacking maintains Warrior Met Coal (NYSE:HCC) with a Neutral and raises the price target from $35 to $40.

HCC

Cracks In The Foundation? Home Sales Tumble As Refinancing Soars

By AJ Fabino

December 21, 12:36 PM

With mortgage rates falling for the fifth consecutive week, newer homeowners who locked in higher rates are looking for ways to reduce their monthly mortgage costs — and they’re doing so by refinancing in flock-like numbers.

VNQ

Canaccord Genuity Downgrades Bioventus to Hold

Related Posts

1606 Corp. Signs Product Distribution Agreement With SurgePays, Inc.

Canadian Marijuana Stock Slightly Up On Q2 Earnings: 9.3% YoY Revenue Growth, Reduced Net Loss

Citigroup Maintains Neutral on Warrior Met Coal, Raises Price Target to $40

Cracks In The Foundation? Home Sales Tumble As Refinancing Soars